Contact this trialFirst, we need to learn more about you.
Cyclin-Dependent Kinase Inhibitor
Lerociclib +1 More for Uterine Cancer
Recruiting1 awardPhase 3
Shreveport, Louisiana
This trial is testing a combination of two drugs, lerociclib and letrozole, in postmenopausal women with advanced or recurrent low-grade endometrial cancer. The goal is to see if this combination is more effective than letrozole alone. Lerociclib helps stop cancer cells from growing, while letrozole lowers estrogen levels to slow cancer growth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service